Skip to main content

Dentsply Sirona Value Stock - Dividend - Research Selection

Dentsply sirona

ISIN: US24906P1093 , WKN: A2AF0E

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Dentsply Sirona to Host Fourth Quarter and Full Year Conference Call on February 26

2026-02-05
CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to review its fourth quarter and full year 2025 financial results. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s

Lifevantage (LFVN) Q2 Earnings and Revenues Lag Estimates

2026-02-04
Lifevantage (LFVN) delivered earnings and revenue surprises of -31.82% and -10.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Assessing Dentsply Sirona (XRAY) Valuation After Softer Results And Ongoing Profitability Concerns

2026-01-31
DENTSPLY SIRONA (XRAY) is back in focus after softer quarterly results, ongoing constant currency revenue declines over the past two years, and weaker return on invested capital raised fresh questions about the quality of its recent growth efforts. See our latest analysis for DENTSPLY SIRONA. The latest share price of $12.47 sits against a mixed backdrop, with a 9.1% 1 month share price return and a 10.65% year to date share price return contrasting with a 33.81% 1 year total shareholder...

Dentsply Sirona’s Revenue Struggles And Capital Woes Test Turnaround Story

2026-01-31
DENTSPLY SIRONA, NasdaqGS:XRAY, is contending with declining revenue and negative return on invested capital, pointing to ongoing business and execution challenges. These issues raise questions about competitive pressures in dental products and equipment and about how effectively management is deploying capital. The developments are material for shareholders, given the share price at $12.47 and a 33.8% decline over 1 year and 64.5% decline over 3 years. For you as an investor, the concern...

Dentsply Sirona (XRAY): Buy, Sell, or Hold Post Q3 Earnings?

2026-01-29
What a brutal six months it’s been for Dentsply Sirona. The stock has dropped 23.6% and now trades at $12.31, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

1 Small-Cap Stock with Competitive Advantages and 2 Facing Challenges

2026-01-27
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Wellspect HealthCare Launches Surity™ Female External Catheter Improving Care for Women Living with Severe Urinary Incontinence

2026-01-26
Wellspect HealthCare, a global provider of continence care solutions, today announced the U.S. launch of the innovative Surity™ Female External Catheter, a new non-invasive solution designed to support women living with severe urinary incontinence. Wellspect HealthCare has been a trusted healthcare leader and at the forefront of innovation for more than 40 years, with established product brands including LoFric® and Navina™. Surity™ marks Wellspect's entry into a new category, bringing people su

Dentsply Sirona (XRAY) Stock Is Up, What You Need To Know

2026-01-21
Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) jumped 3.8% in the afternoon session after Mizuho analyst Steven Valiquette raised the price target on the stock.

8.5% Yield From IG-Rated Dentsply Sirona Bonds Still Look Interesting

2026-01-16
Explore Dentsply Sirona (XRAY): global dental tech leader, key segments, and why its investment-grade bonds yielding 8.5% stand out—read now.

How Expanded U.S. Distribution And Board Changes At DENTSPLY SIRONA (XRAY) Have Changed Its Investment Story

2026-01-15
DENTSPLY SIRONA recently renewed its U.S. dental technology distribution agreement with Patterson Dental and expanded its long-standing collaboration with Benco Dental, ensuring continued access to its CEREC system, Primescan scanners, and Axeos and Orthophos imaging solutions for dental practices nationwide. Alongside these distribution moves, the company added former Patterson CEO Donald Zurbay to its Board and formed a Growth and Value Creation Committee, signaling a reinforced push...